Cleveland Clinic Medicine Institute, 9500 Euclid Avenue/G10, Cleveland, Ohio 44195, USA.
Clin J Am Soc Nephrol. 2011 Aug;6(8):1858-65. doi: 10.2215/CJN.00500111. Epub 2011 Jul 22.
Chronic kidney disease (CKD) is prevalent in minority populations and racial/ethnic differences in survival are incompletely understood.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Secondary analysis of Kidney Early Evaluation Program participants from 2000 through 2008 with CKD, not on dialysis, and without previous kidney transplant was performed. Self-reported race/ethnicity was categorized into five groups: non-Hispanic white, African American, Asian, American Indian/Alaska Native, and Hispanic. CKD was defined as a urinary albumin to creatinine ratio of ≥30 mg/g among participants with an estimated GFR (eGFR) ≥60 ml/min per 1.73 m(2) or an eGFR of <60 ml/min per 1.73 m(2). The outcome was all-cause mortality. Covariates used were age, sex, obesity, diabetes, hypertension, albuminuria, baseline eGFR, heart attack, stroke, smoking, family history, education, health insurance, geographic region, and year screened.
19,205 participants had prevalent CKD; 55% (n = 10,560) were White, 27% (n = 5237) were African American, 9% (n = 1638) were Hispanic, 5% (n = 951) were Asian, and 4% (n = 813) were American Indian/Alaska Native. There were 1043 deaths (5.4%). African Americans had a similar risk of death compared with Whites (adjusted Hazard Ratio (AHR) 1.07, 95% CI 0.90 to 1.27). Hispanics (AHR 0.66, 95% CI 0.50 to 0.94) and Asians (AHR 0.63, 95% CI 0.41 to 0.97) had a lower mortality risk compared with Whites. In contrast, American Indians/Alaska Natives had a higher risk of death compared with Whites (AHR 1.41, 95% CI 1.08 to 1.84).
Significant differences in mortality among some minority groups were found among persons with CKD detected by community-based screening.
慢性肾脏病(CKD)在少数民族中较为普遍,种族/民族之间的生存差异尚不完全清楚。
设计、设置、参与者和测量:对 2000 年至 2008 年期间参加肾脏早期评估计划的、未接受透析且无既往肾移植的 CKD 患者进行了二次分析。自我报告的种族/民族分为五组:非西班牙裔白人、非裔美国人、亚洲人、美洲印第安人/阿拉斯加原住民和西班牙裔。CKD 的定义为估计肾小球滤过率(eGFR)≥60 ml/min/1.73 m2 的患者中尿白蛋白与肌酐比值≥30 mg/g,或 eGFR<60 ml/min/1.73 m2。结局是全因死亡率。使用的协变量包括年龄、性别、肥胖、糖尿病、高血压、白蛋白尿、基线 eGFR、心脏病发作、中风、吸烟、家族史、教育、医疗保险、地理位置和筛查年份。
19205 例患者患有现患 CKD;55%(n=10560)为白人,27%(n=5237)为非裔美国人,9%(n=1638)为西班牙裔,5%(n=951)为亚洲人,4%(n=813)为美洲印第安人/阿拉斯加原住民。有 1043 人死亡(5.4%)。非裔美国人的死亡风险与白人相似(调整后的危险比(AHR)1.07,95%CI 0.90 至 1.27)。与白人相比,西班牙裔(AHR 0.66,95%CI 0.50 至 0.94)和亚洲人(AHR 0.63,95%CI 0.41 至 0.97)的死亡率较低。相比之下,美洲印第安人/阿拉斯加原住民的死亡风险高于白人(AHR 1.41,95%CI 1.08 至 1.84)。
在通过社区筛查发现的 CKD 患者中,一些少数族裔群体的死亡率存在显著差异。